Inventor · disambiguated record
Aaron Ciechanover
Also filed as: CIECHANOVER AARON · CIECHANOVER AARON J
9 granted patents·5 pending applications·81 citations·filing 1993–2025
86Inventor score
Files withTECHNION RES & DEV FOUNDATION5RAPPAPORT FAMILY INST FOR RES2SIGNAL PHARM INC2MANNING ANTHONY M1SIGNAL PHARM LLC1
Top patents by PatentIndex Score
14 records- 0180US6656713B2Compounds and methods for modulating activation of NF-κBSIGNAL PHARM INC·Filed 2001·Granted Dec 2, 2003·14 cites·7 claims
- 0275US7414120B2Compounds and methods for modulating activation of NF-κBSIGNAL PHARMACEUTICALS·Filed 2007·Granted Aug 19, 2008·2 cites·7 claims
- 0372US5932425ACompositions and methods for modulating cellular NF-κB activationSIGNAL PHARM INC·Filed 1997·Granted Aug 3, 1999·35 cites·7 claims
- 0464US7186503B2Compounds and methods for modulating activation of NF-κBSIGNAL PHARM LLC·Filed 2003·Granted Mar 6, 2007·2 cites·4 claims
- 0564US2025325508A1Modulators of proteasome dynamics and/or function, compositions, methods, and therapeutic uses thereofTECHNION RES & DEV FOUNDATION·Filed 2025·Application pending·0 cites
- 0660US5384255AUbiquitin carrier enzyme E2-F1, purification, production, and useRAPPAPORT FAMILY INST FOR RES·Filed 1993·Granted Jan 24, 1995·28 cites·1 claims
- 0756US8263326B2Compounds and methods for modulating activation of NF-κBMANNING ANTHONY M·Filed 2008·Granted Sep 11, 2012·0 cites·5 claims
- 0855US12421510B2Peptide, a complex and a method for treating cancerTECHNION RES & DEV FOUNDATION·Filed 2019·Granted Sep 23, 2025·0 cites·19 claims
- 0954US2023095010A1Ubiquitin ligase kpc1 promotes processing of p105 nf-kappab1 to p50, eliciting strong tumor suppressionTECHNION RES & DEV FOUNDATION·Filed 2022·Application pending·0 cites
- 1050US7507788B2Peptides and methods for cell death regulationRAPPAPORT FAMILY INST FOR RES·Filed 2003·Granted Mar 24, 2009·0 cites·5 claims
- 1149US2023330064A1TYROSINE, TRYPTOPHAN AND PHENYLALANINE AS mTOR AGONISTS MEDIATING PROTEASOME DYNAMICS, COMPOSITIONS, METHODS AND USES THEREOF IN THERAPY, AND PROGNOSTIC METHODS FOR DRUG-RESISTANCETECHNION RES & DEV FOUNDATION·Filed 2021·Application pending·0 cites
- 1245US2004247589A1Anti-tumor activity from reptile serumFiled 2004·Application pending·0 cites
- 1337US11452759B2Ubiquitin ligase KPC1 promotes processing of P105 NF-κB1 to p50, eliciting strong tumor suppressionTECHNION RES & DEV FOUNDATION·Filed 2016·Granted Sep 27, 2022·0 cites·7 claims
- 1436US2006058229A1Peptides and methods for cell death regulationSTELLER HERMANN·Filed 2003·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Aaron Ciechanover files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →